Showing results (61-70 of 89) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2021
ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel AdenocarcinomaKatrina S Pedersen, Nathan R Foster, Michael J Overman, et al.Journal of Applied Clinical Medical Physics|September 11, 2014
Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumorsTerence T Sio, Andrew R Jensen, Robert C Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Thymidylate synthase expression in colon carcinomas with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.Plos One|October 14, 2014
MRE11-deficiency associated with improved long-term disease free survival and overall survival in a subset of stage III colon cancer patients in randomized CALGB 89803 trialThomas Pavelitz, Lindsay Renfro, Nathan R Foster, et al.JNCI Cancer Spectrum|September 6, 2021
Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon CancerFrank A Sinicrope, Qian Shi, Thomas C Smyrk, et al.Pancreas|March 14, 2014
Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumabKatherine Van Loon, Anne M Espinoza, David R Fogelman, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 24, 2014
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2024
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid CancersJena D French, Bryan R Haugen, Francis P Worden, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancerDaniel J Sargent, Silvia Marsoni, Genevieve Monges, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404)Alan L Ho, Nathan R Foster, Alex J Zoroufy, et al.Pageof 9